# Fresenius, Bayer and Knauf Executives Discuss India Manufacturing and Investment With Piyush Goyal

> Piyush Goyal met Fresenius, Bayer and Knauf executives in Berlin to discuss expanding manufacturing, investment and healthcare collaboration in India.

- Published: 2026-10-23T03:38:05+00:00
- Section: Partnerships
- Author: News Desk
- URL: https://newsforagent.com/news/2026-10-23/fresenius-bayer-knauf-india-goyal-berlin
- Source: [The Tribune](https://www.tribuneindia.com/news/collaboration/piyush-goyal-holds-talks-with-fresenius-bayer-knauf-executives-to-explore-deeper-india-collaboration)

## Key takeaways

- Piyush Goyal held separate meetings in Berlin with Michael Sen of Fresenius, Stefan Oelrich of Bayer and Murat Akyildiz of Knauf Group.
- Goyal said the Fresenius talks covered India's healthcare demand, medical solutions and manufacturing capabilities.
- Knauf Group plans to invest an additional €350 million in India and establish four new plants, including a third plant in Gujarat with €80 million.

Union Minister of Commerce and Industry Piyush Goyal met senior executives of Fresenius Group, Bayer and Knauf Group in Berlin on October 23 to discuss expanding manufacturing, increasing investment and strengthening collaboration in healthcare, pharmaceuticals, sustainable construction materials and infrastructure. [The Tribune](https://www.tribuneindia.com/news/collaboration/piyush-goyal-holds-talks-with-fresenius-bayer-knauf-executives-to-explore-deeper-india-collaboration) carried the report.

## Fresenius, Bayer and Knauf Talks in Berlin

Goyal met Michael Sen, CEO of [Fresenius](https://akta.pro/company-profiles/00034eh/fresenius), to discuss strengthening healthcare collaboration by drawing on India's growing demand for quality and affordable medical solutions and its manufacturing capabilities. "Discussed opportunities to deepen collaboration in healthcare, leveraging India's rapidly expanding healthcare sector, growing demand for quality and affordable medical solutions, and strong manufacturing capabilities," Goyal said. He said the discussions covered how Fresenius could use India's skilled workforce and production capabilities to serve domestic and international markets.

In a second meeting, Goyal discussed Bayer's expansion plans in India with Stefan Oelrich, President of the Pharmaceuticals Division at [Bayer](https://akta.pro/company-profiles/00000x6/bayer). "Discussed Bayer's expansion plans in India & opportunities to deepen its engagement in our robust healthcare ecosystem through greater investment, innovation & collaboration," the minister said.

Goyal also met Murat Akyildiz, Global General Partner at [Knauf Group](https://akta.pro/company-profiles/000bghm/knauf-group), to discuss the company's expanding manufacturing presence in India and opportunities for further collaboration. The talks covered sustainable construction materials and infrastructure development, which Goyal linked to India's urbanisation and economic transformation. "Discussed Knauf's expanding manufacturing in India and avenues to deepen collaboration across sustainable construction materials and infrastructure development, aligning with India's unprecedented urban and economic transformation," he said. The Tribune reported on October 22 that Knauf Group plans to invest an additional €350 million in India and establish four new plants, including a third plant in Gujarat with €80 million.

## Fresenius Healthcare Partnerships on Record

According to akta.pro [company records](https://akta.pro/company-data), Fresenius and SAP jointly invested in Avelios Medical in June 2026 to co-develop a next-generation cloud-native hospital information system as the foundation of an open, AI-enabled digital healthcare ecosystem. In January 2026, SAP and Fresenius announced a strategic partnership to build a sovereign, interoperable, AI-supported healthcare platform. Fresenius Kabi entered a partnership with U.S. manufacturer Phlow Corp. in February 2026 to establish a fully domestic, end-to-end supply chain for Epinephrine Injection, USP. The same records show Fresenius generated €22.5-22.6 billion in annual revenue in fiscal year 2025, with Fresenius Kabi reporting sales of more than €8.5 billion and Fresenius Helios more than €13.5 billion.

## Fresenius Leadership Changes Before the Berlin Meetings

Fresenius appointed Marc-Alexander Mahl as CEO of Fresenius Kabi, effective November 1, replacing Pierluigi Antonelli, FinanzNachrichten.de reported in October 2026. The supervisory board also extended CFO Sara Hennicken's contract by five years to 2032. Global Venturing reported in October 2026 that Nipun Juneja was appointed investment strategy director at Fresenius Ventures, the corporate VC arm of Fresenius, and that the fund, launched in July 2026, will invest about €40m annually over five years in medtech and related areas.

## Companies in this story

- [Fresenius company profile](https://akta.pro/company-profiles/00034eh/fresenius) · website: http://www.fresenius.com
- [Knauf Group company profile](https://akta.pro/company-profiles/000bghm/knauf-group) · website: https://www.knauf.com
- [Bayer company profile](https://akta.pro/company-profiles/00000x6/bayer) · website: https://www.bayer.com

---
News for Agent · https://newsforagent.com/llms.txt